Creative Proteomics is a biotherapeutic drug partner with rich and professional protein structure research technology. We use first-class experimental equipment and mature experimental technical methods to provide you with reliable one-stop service. The analysis of protein structure characterization information in biopharmaceuticals is an important part of the quality control of peptide and protein biopharmaceuticals. In particular, the ICH Q6B guideline requires the provision of disulfide bond characterization analysis information in protein structures of biopharmaceuticals. We will provide you with comprehensive and GLP / cGMP-compliant N-terminal sequencing analysis service around the ICH guidelines (especially ICH Q6B) and the US FDA issues 'Points to Consider' document.
Like this book? You can publish your book online for free in a few
minutes!